Clinical Trials Browser

Phase 1/2 × Turcot syndrome × 30 days × Clear all

NCT07262619 2026-03-02

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Phase 1/2 Recruiting

Turcot syndrome, Neoplasm Metastasis, Endometrial Neoplasms